Marjolein J. Kagie - Concepedia

Concepedia

Author

Marjolein J. Kagie

Leiden University Medical Center

Also Known As

M J Kagie, M J. Kagie, M. J. Kagie, M. Kagie, M.J. KAGIE, M.J. Kagie, Marjolein J Kagie, Marjolein J. Kagie, Marjolein Kagie

35

Publications

1.1K

Citations

13

H-Index

21

Concepts

All Affiliations

Leiden University Medical Center Medisch Centrum Haaglanden Leiden University The Netherlands Cancer Institute Erasmus MC

MJ

About

Marjolein J. Kagie is an author at Leiden University Medical Center specializing in medicine, obstetrics, and human papillomavirus vaccines.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	297
2	Obstetrics	2	2	129
3	Public Health	1	1	68
4	Anatomy	1	1	168
5	Immunology	1	1	68

Marjolein J. Kagie

×

13

Publications

1.1K

Citations

13

H-Index

	Year	Citations
Treatment of Vulvar Intraepithelial Neoplasia with Topical Imiquimod Manon van Seters, Marc van Beurden, Fiebo J.W. ten Kate, New England Journal of Medicine	2008	389
Limb body wall malformation complex: An embryologic etiology? N. G. Hartwig, Chr. Vermeij‐Keers, Helga E. de Vries, Human Pathology Developmental AnomalyThumb HypoplasiaGross AnatomyDevelopmental BiologyEmbryologic Etiology	1989	168
Vaccination against Oncoproteins of HPV16 for Noninvasive Vulvar/Vaginal Lesions: Lesion Clearance Is Related to the Strength of the T-Cell Response Mariëtte I.E. van Poelgeest, Marij J.P. Welters, Renee Vermeij, Clinical Cancer Research	2016	163
The long-term immune response after HPV16 peptide vaccination in women with low-grade pre-malignant disorders of the uterine cervix: a placebo-controlled phase II study Peggy J. de Vos van Steenwijk, Mariëtte I.E. van Poelgeest, Tamara H. Ramwadhdoebé, Cancer Immunology Immunotherapy VaccinationCancer-associated VirusVaccine DevelopmentCervical CancerHuman Papillomavirus Vaccines	2013	68
Human Papillomavirus Infection in Squamous Cell Carcinoma of the Vulva, in Various Synchronous Epithelial Changes and in Normal Vulvar Skin Marjolein J. Kagie, Gemma G. Kenter, Yvonne Zomerdijk-Nooijen, Gynecologic Oncology Vulvar DiseasesSquamous Cell CarcinomaHuman Papillomavirus VaccinesGynecologyVirology	1997	61
p53 protein overexpression is common and independent of human papillomavirus infection in squamous cell carcinoma of the vulva Marjolein J. Kagie, Gemma G. Kenter, Rob A.�E.�M. Tollenaar, Cancer	1997	46
p53 Protein Overexpression, a Frequent Observation in Squamous Cell Carcinoma of the Vulva and in Various Synchronous Vulvar Epithelia, Has No Value as a Prognostic Parameter Marjolein J. Kagie, Gemma G. Kenter, Rob A.�E.�M. Tollenaar, International Journal of Gynecological Pathology	1997	44
β‐glucuronidase deficiency as a cause of fetal hydrops Marjolein J. Kagie, Wim J. Kleijer, J. G. M. Huijmans, American Journal of Medical Genetics	1992	37
Validation and Implementation of BRCA1/2 Variant Screening in Ovarian Tumor Tissue Marthe M. de Jonge, Dina Ruano, Ronald van Eijk, Journal of Molecular Diagnostics	2018	24
Low preoperative skeletal muscle density is predictive for negative postoperative outcomes in older women with ovarian cancer Vera van der Zanden, Neeltje J. van Soolingen, Alain R. Viddeleer, Gynecologic Oncology	2021	23

Page 1